GROWING IMPACT OF BLOOD CANCER ON WOMEN Increasing incidence rates, mortality and disease burden forecast over coming decade
With
Chris Tanti, CEO
Leukaemia Foundation
SEGMENT
Filmed in Melbourne | December 2025
According to the Leukaemia Foundation, blood cancer is one of the most urgent and under-recognised women’s health issues in Australia, with three times more Australian women diagnosed with blood cancer than ovarian and cervical cancer combined (Source: AIHW, Cancer Data in Australia, 2024).
Blood cancer has also emerged as the second most common cancer diagnosed in Australian women overall – behind only breast cancer – and the leading cancer amongst girls and women under the age of 30 (Source: AIHW, Cancer Data in Australia, 2024).
Women face longer, more intensive treatment regimens than many other cancers, often requiring lengthy hospital stays or relocation to a capital city to access specialist care. Treatments such as chemotherapy and radiotherapy can also cause irreversible infertility.
The financial and emotional burden of blood cancer on women is equally severe:
- Women with blood cancer are more likely to be out of work than those with other leading cancers.
- 42% of patients are forced to take more than three months off work, 30% leave their jobs entirely, and half have not been able to return to work.
- Patients face average out-of-pocket costs of $5,000–$11,000, compared to $2,500 for other cancers
- 70% of people with blood cancer experience emotional challenges after diagnosis.
Women also make up 72% of Australia’s primary carers, yet with a debilitating diagnosis like blood cancer, their ability to care for others is significantly diminished, impacting families and communities nationwide.
Australian Health Journal spoke with Leukaemia Foundation CEO, Chris Tanti about the toll, blood cancer takes on women’s lives beyond the physical fight for survival, as well as the alarming forecasts on the expected increase over the next decade. Mr Tanti talks about the need to increased levels of medical research into blood cancer to balance against other leading cancers, to investigate prevention, early detection, and diagnosis.
About Leukaemia Foundation
For the past 50 years, the Leukaemia Foundation has been caring for and supporting Australians affected by blood cancer by providing accommodation while they are undergoing treatment, assistance with transport to appointments, education and information about their blood cancer, as well as other practical, financial, emotional and mental health support.
Source: Adapted from Leukaemia Foundation media release September 2025
-
Family biz succeeds in vaccine approval & distribution
It’s been 10 years since Jenny and Karl Herz started in business. Over the past 10 years they’ve launched Biointelect and Biocelect businesses to help secure approval and distribution for new medicines into Australia.
In this Australian Health Journal interview, Jenny and Karl talk about the journey the husband and wife team took to get the Novavax COVID-19 vaccine (Nuvaxovid) approved and distributed in Australia. The journey didn’t just include talented and diverse skilled staff but also their children working in both organisations.
-
New bar for cosmetic plastic surgeon accreditation
Population screening is an important contributor to advancing health outcomes through the early detection of and successful intervention for chronic disease. The evolution of science, technology and evidence relating to diseases which are or may be amenable to a population screening approach deserve broad discussion and the sharing of expertise and evidence. They also warrant close scrutiny in context of health policy and health resource allocation considerations.
In March, Public Health Association of Australia (PHAA) convened Screening Conference Conference 2025 with the theme of ‘Population Screening for Chronic Disease – Maximising Benefits, Minimising Harms’.
-
Emerging researcher appointed to James Packer Chair in Mood Disorders at UNSW
The UNSW Discipline of Psychiatry and Mental Health is widely renowned as the pre-eminent psychiatry research department in the country and one of the leading university psychiatry research groups internationally. In 2023 it celebrated 60 Years of Psychiatry & Mental Health at UNSW Sydney.
Australian Health Journal spoke with Professor Kimberlie Dean, Head of the Discipline of Psychiatry and Mental Health at UNSW Sydney, about the recent appointment of mental health disorders expert and clinician researcher Dr Aswin Ratheesh to lead the James Packer Chair in Mood Disorders at UNSW Sydney.
